Description:

Z1031 Preoperative Endocrine Prognostic Index Form (PEPI) Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=739D9DB4-532C-7818-E040-BB89AD4371E4

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=739D9DB4-532C-7818-E040-BB89AD4371E4

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Endometrial Cancer NCT00265759 On-Study - Z1031 Preoperative Endocrine Prognostic Index Form (PEPI) - 2940238v1.0

This form is to be completed using information from the "PEPI Worksheet." The worksheet will be completed by the ACOSOG Central Laboratory and returned after surgery. Please contact the lab with questions: (314) 454-7615

Unnamed 1
Visit
Preoperative Endocrine Prognostic Index/treatment Information
Did patient complete protocol AI therapy
Treatment Plan (Per protocol: Chemotherapy is not recommended for patients with PEPI score = 0 and pathological stage T1N0 or T0N0 pathologic complete response)
Footer Module

Similar models